Biocept, Inc. (BIOC) - Medical Equipment - Deals and Alliances Profile

Date: October 18, 2016
Pages: 70
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: B796D7BF985EN
Leaflet:

Download PDF Leaflet

Biocept, Inc. (BIOC) - Medical Equipment - Deals and Alliances Profile
Summary

Biocept, Inc. (Biocept) is a medical equipment company that provides diagnostics services. The company provides biopharmaceutical and clinical research, and molecular oncology laboratory services. It provides tests for various solid tumor cancers. Biocept offers OncoCEE technology, related instrumentation and analytical capabilities for rare event detection and genetic characterization. The company’s OncoCEE platform modifies rare cell capture and analyses methods. It offers patented methodology to isolate rare cells including circulating tumor cells, and cell-free circulating tumor DNA from the blood. The company caters to medical and surgical oncologists, pathologists, hospitals, cancer centers, universities, and pharmaceutical and clinical researchers. Biocept is headquartered in San Diego, California, the US.

Biocept, Inc. (BIOC) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company.
Biocept, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Biocept, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016
Biocept, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Biocept, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016
Biocept, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016
Biocept, Inc., Medical Equipment, Deal Details
Venture Financing
Biocept Raises Funds In Growth Equity Financing Round
Biocept Raises US$2.3 Million In Venture Financing
Biocept Raises US$3.6 Million In Financing Round
Partnerships
Biocept Enters into Agreement with Teneovita Medical Innovations
Biocept Forms Partnership with MedStar Georgetown University Hospital
Biocept to Form Partnership with Quest Diagnostics Mexico
Biocept Enters into Agreement
Biocept Enters into Distribution Agreement with Progenetics
Biocept Enters into Co-Development Agreement with Baylor College of Medicine
Biocept Enters into Partnership with Life Technologies
Biocept Enters Into Co-Marketing Agreement With Clarient
Equity Offering
Biocept Prices Public Offering of Shares and Warrants for USD10 Million
Biocept Prices Public Offering of Shares and Warrants for USD5 Million
Biocept to Raise USD15 Million in Public Offering of Shares
Biocept Prices Public Offering of Shares and Warrants for USD10 Million
Biocept Completes IPO For US$19 Million
Biocept Raises USD2 Million in Private Placement of Series A Preferred Stock
Biocept, Inc. - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Recent Developments
Strategy And Business Planning
Sep 28, 2015: Biocept Announces Participation in MultiPlan’s Networks
Sep 14, 2015: Biocept Secures Agreements with Preferred Provider Organizations Stratose and Galaxy Health Network for its Proprietary Blood-Based Oncology Diagnostic Assays
Aug 11, 2015: Biocept and University of California, Irvine to Study Blood-based Liquid Biopsy Testing in Cancer Patients
Financial Announcements
Aug 02, 2016: Biocept Reports 2016 Second Quarter Financial Results
May 12, 2016: Biocept Reports 2016 First Quarter Financial Results
Mar 09, 2016: Biocept Reports 2015 Fourth Quarter and Full Year Financial Results
Nov 05, 2015: Biocept Reports Third Quarter 2015 Financial Results
Aug 10, 2015: Biocept Reports Second Quarter 2015 Financial Results
May 12, 2015: Biocept Reports First Quarter 2015 Financial Results
Mar 09, 2015: Biocept Reports Fourth Quarter 2014 Financial Results
Corporate Communications
Jul 27, 2016: Biocept Appoints Timothy C. Kennedy as Chief Financial Officer and Senior Vice President of Operations
Aug 21, 2015: Biocept Announces Personnel Change
Aug 03, 2015: Dr. Marileila Varella Garcia Joins Biocept as Scientific Advisor
Mar 05, 2015: Next Generation Sequencing Veteran Joins Biocept
Mar 02, 2015: Dr. David Rimm Joins Biocept as a Scientific Advisor
Product News
Feb 26, 2016: Data Demonstrating Extremely High Sensitivity of Biocept's Blood-Based Liquid Biopsy in Detecting Lung Cancer Mutations Presented at UCSD Moores Cancer Center Translational Oncology Symposium
Sep 08, 2015: Biocept's Liquid Biopsy Lung Cancer Target Selector Assay to be featured at World Conference on Lung Cancer
Mar 10, 2015: Biocept Expands Non-Small Cell Lung Cancer Diagnostic Capabilities for EGFR Mutations
Other Significant Developments
Sep 09, 2016: Biocept to Collaborate with Renowned Clinical Investigator Dr. Shilpa Gupta to Study the Utility of Liquid Biopsy Testing in Bladder and Prostate Cancers
Aug 11, 2016: Biocept Expands Distribution of Liquid Biopsy Tests to the Philippines
May 23, 2016: Biocept Announces Master Services Agreement with Pharma Company to Develop Liquid Biopsy Tests
Mar 23, 2016: Biocept's Mark Foletta Honored with CFO Lifetime Achievement Award
Mar 10, 2016: Progenetics to Distribute Biocept's Liquid Biopsy Assays in Israel
Feb 29, 2016: Biocept Secures Agreement with Preferred Provider Organization Prime Health Services
Jan 12, 2016: Biocept Announces In-Network Agreement with Blue Cross Blue Shield of Illinois
Nov 23, 2015: Biocept Secures Agreements with Preferred Provider Organizations Fortified Provider Network and Three Rivers Provider Network
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer 70

LIST OF TABLES

Biocept, Inc., Medical Equipment, Key Facts, 2015
Biocept, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016
Biocept, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Biocept, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016
Biocept, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Biocept, Inc., Deals By Market, 2010 to YTD 2016
Biocept, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016
Biocept Raises Funds In Growth Equity Financing Round
Biocept Raises US$2.3 Million In Venture Financing
Biocept Raises US$3.6 Million In Financing Round
Biocept Enters into Agreement with Teneovita Medical Innovations
Biocept Forms Partnership with MedStar Georgetown University Hospital
Biocept to Form Partnership with Quest Diagnostics Mexico
Biocept Enters into Agreement
Biocept Enters into Distribution Agreement with Progenetics
Biocept Enters into Co-Development Agreement with Baylor College of Medicine
Biocept Enters into Partnership with Life Technologies
Biocept Enters Into Co-Marketing Agreement With Clarient
Biocept Prices Public Offering of Shares and Warrants for USD10 Million
Biocept Prices Public Offering of Shares and Warrants for USD5 Million
Biocept to Raise USD15 Million in Public Offering of Shares
Biocept Prices Public Offering of Shares and Warrants for USD10 Million
Biocept Completes IPO For US$19 Million
Biocept Raises USD2 Million in Private Placement of Series A Preferred Stock
Biocept, Inc., Key Competitors
Biocept, Inc., Key Employees 34

LIST OF FIGURES

Biocept, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016
Biocept, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Biocept, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Biocept, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016
Biocept, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Biocept, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016
Biocept, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Biocept, Inc., Medical Equipment, Deals by Market, 2010 to YTD 2016
Skip to top


Ask Your Question

Biocept, Inc. (BIOC) - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: